Related Experiment Video
Updated: May 30, 2026

Purification of Ubiquitinated p53 Proteins from Mammalian Cells
Published on: March 21, 2022
Regulation of MITF stability by the USP13 deubiquitinase
Xiansi Zhao1, Brian Fiske, Akinori Kawakami
1Cutaneous Biology Research Center & Melanoma Program, Department of Dermatology, Massachusetts General Hospital, Harvard Medical School, Boston, USA.
Abstract:
The microphthalmia-associated transcription factor (MITF) is essential for melanocyte development. Mutation-induced MAPK pathway activation is common in melanoma and induces MITF phosphorylation, ubiquitination, and proteolysis. Little is known about the enzymes involved in MITF ubiquitination/deubiquitination. Here we report the identification of a deubiquitinating enzyme, named ubiquitin-specific protease 13 (USP13) that appears to be responsible for MITF deubiquitination, utilizing a short hairpin RNA library against known deubiquitinating enzymes. Through deubiquitination, USP13 stabilizes and upregulates MITF protein levels. Conversely, suppression of USP13 (through knockdown) leads to dramatic loss of MITF protein, but not messenger RNA. Through its effects on MITF deubiquitination, USP13 was observed to modulate expression of MITF downstream target genes and, thereby, to be essential for melanoma growth in soft agar and in nude mice. These observations suggest that as a potentially drugable protease, USP13 might be a viable therapeutic target for melanoma.
Insights
Ubiquitin-specific protease 13 (USP13) deubiquitinates and stabilizes microphthalmia-associated transcription factor (MITF). USP13 is essential for melanoma cell growth, suggesting it as a potential therapeutic target.
Area of Science:
- Molecular Biology
- Cancer Biology
- Biochemistry
Background:
- Microphthalmia-associated transcription factor (MITF) is crucial for melanocyte development and is often dysregulated in melanoma.
- MAPK pathway activation in melanoma leads to MITF degradation, but the enzymes controlling MITF ubiquitination/deubiquitination remain largely unknown.
Purpose of the Study:
- To identify enzymes responsible for microphthalmia-associated transcription factor (MITF) deubiquitination.
- To investigate the role of USP13 in regulating MITF levels and melanoma progression.
Main Methods:
- Utilized a short hairpin RNA library targeting deubiquitinating enzymes to screen for MITF-interacting proteases.
- Performed knockdown experiments to assess the impact of USP13 on MITF protein and mRNA levels.
- Analyzed the effect of USP13 on MITF downstream gene expression and melanoma cell proliferation in vitro and in vivo.
Main Results:
- Identified ubiquitin-specific protease 13 (USP13) as a key deubiquitinating enzyme for MITF.
- USP13 stabilizes MITF protein levels, while USP13 suppression leads to MITF degradation without affecting its mRNA.
- USP13 modulates MITF target gene expression, promoting melanoma growth in soft agar and in mouse models.
Conclusions:
- USP13 plays a critical role in stabilizing MITF protein levels through deubiquitination.
- USP13 is essential for melanoma cell growth and progression.
- USP13 represents a potential therapeutic target for melanoma treatment.
Related Concept Videos
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein.
Regulated Protein Degradation
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Regulated Protein Degradation
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Abnormal Proliferation
Regulation of Expression at Multiple Steps
mRNA Stability and Gene Expression
Cis-acting Elements involved in mRNA stability

